Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
about
Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux diseaseEfficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study.Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitorsClinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux diseaseTransoral incisionless fundoplication: current statusTransoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.Laparoscopic Nissen fundoplication in the treatment of Barrett's esophagus - 10 years of experience.Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical TrialACG practice guidelines: esophageal reflux testing.Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial.Multimodal pain stimulations in patients with grade B oesophagitisEndoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial.Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease.Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.Experimental human pain models in gastro-esophageal reflux disease and unexplained chest painAnti-Oxidative and Anti-Inflammatory Effects of QGC in Cultured Feline Esophageal Epithelial Cells.Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results.Clinical and pH study characteristics in reflux patients with and without ineffective oesophageal motility (IEM).Refractory gastroesophageal reflux disease.Patients with refractory reflux symptoms: What do they have and how should they be managed?Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device.Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice.Ambulatory pH Monitoring: New Advances and Indications.Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation.The effect of oral administration of ursodeoxycholic acid and high-dose proton pump inhibitors on the histology of Barrett's esophagus.Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.Patients with symptoms of delayed gastric emptying have a high prevalence of oesophageal dysmotility, irrespective of scintigraphic evidence of gastroparesis.Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy
P2860
Q27027594-4512D9DE-366A-4B20-B46A-D2FFF88792D9Q30613552-70F9A4AB-580B-44DA-AFE7-69A36FB4D33EQ33337244-6C51FD94-7A10-4A31-8A4D-78781019D08DQ33448888-2003F842-C17C-4321-BA82-87572E7D0A1EQ33467555-CFCCB5A4-97A8-446F-AF2E-3B3323856733Q33725981-8970915A-F259-47B2-82B0-85F483B25376Q34356211-C669F52B-A304-4923-BF73-D648AECEA4EFQ34416676-B8514941-68C0-47A8-8D21-2FDE5958E9EEQ34576807-0B257367-71B6-4796-93B9-962DE161F01BQ34947112-D7FE0DF5-759D-4514-93E3-94E340530012Q35760744-8D3B235E-645A-406B-B53A-8DECA0EE4ABCQ35761233-C024262D-EF19-476B-A83A-C3CD889E5E3CQ36398669-E8315753-8C39-41EF-901E-02F9E2E102AFQ36398674-ED5F717F-60C2-4C84-86D9-18C53AC401E6Q36485768-6BC66A48-D5B4-4DB5-BEB0-CE9A6F274FF9Q36628805-0CEC8EE5-13FB-436B-9290-DE4BDE8B05FFQ37017659-63619120-5033-4EB4-9527-3AAEE233FF0DQ37521980-29289E8C-AA3C-46A2-A96B-1EC9C0EBEDCBQ38255997-B62CD226-EA16-4B24-9DF0-754F3AE8032BQ38572793-D0B327C6-999C-457A-887B-99C1A3881684Q38946177-5A4877DF-91B3-4871-AE39-F0C6166AC71AQ39271435-592014AE-1587-42B9-BD7F-0ACD8EDE83EBQ40274540-0D00DD59-508A-40D4-970C-25788EDC6B01Q43266030-9A6BBD03-F970-44D7-9E1C-FF405FD0F33EQ46079747-57923619-4B13-4AE6-8EE7-01CDC7306314Q46598122-7DD0A8C8-9365-4F6F-88A1-76CD5FED9B13Q47639901-BA8F67C1-1725-48FF-B97C-A9F91366599DQ47772924-32D1AC01-5708-4F75-A77A-CB1CA1B3BA54Q49612871-37015F4F-B6F5-47E8-AB21-A05A8FD89C18Q56774876-45624709-EC38-4EBC-BAB6-1CBE2ECB342E
P2860
Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Complete elimination of reflux ...... phageal reflux disease (GERD).
@en
Complete elimination of reflux ...... astroesophageal reflux disease
@nl
type
label
Complete elimination of reflux ...... phageal reflux disease (GERD).
@en
Complete elimination of reflux ...... astroesophageal reflux disease
@nl
prefLabel
Complete elimination of reflux ...... phageal reflux disease (GERD).
@en
Complete elimination of reflux ...... astroesophageal reflux disease
@nl
P2860
P1476
Complete elimination of reflux ...... phageal reflux disease (GERD).
@en
P2093
David Milkes
Lauren B Gerson
P2860
P304
P356
10.1111/J.1572-0241.2004.30124.X
P407
P577
2004-06-01T00:00:00Z